FHIR © HL7.org  |  Server Home  |  XIG Home  |  Server Source  |  FHIR  

FHIR IG Statistics: ValueSet/HIV.C.DE17

Packagesmart.who.int.hiv
TypeValueSet
IdHIV.C.DE17
FHIR VersionR4
Sourcehttp://smart.who.int/hiv/file://C:\work\release\source\output/ValueSet-HIV.C.DE17.html
URLhttp://smart.who.int/hiv/ValueSet/HIV.C.DE17
Version1.0.0
Statusactive
Date2025-07-08T23:21:58+02:00
NameHIVCDE17
TitleCurrent PrEP regimen ValueSet
Authoritywho
DescriptionValue set of HIV pre-exposure prophylaxis (PrEP) regimen

Resources that use this resource

StructureDefinition
HIVCPrEPvisitHIV.C PrEP visit
HivCurrentPrepRegimenPrescriptionCurrent PrEP Regimen Prescription

Resources that this resource uses

CodeSystem
HIVConceptsWHO SMART HIV Concepts CodeSystem

Narrative

Note: links and images are rebased to the (stated) source

Generated Narrative: ValueSet HIV.C.DE17

  • Include these codes as defined in http://smart.who.int/hiv/CodeSystem/HIVConcepts
    CodeDisplayDefinition
    HIV.C.DE18TDF + FTCTreated with tenofovir disoproxil fumarate (TDF) and emtricitabine (FTC) pre-exposure prophylaxis (PrEP) regimen (oral PrEP)
    HIV.C.DE19TDFTreated with single-agent tenofovir disoproxil fumarate (TDF) pre-exposure prophylaxis (PrEP) regimen (oral PrEP)
    HIV.C.DE20TDF + 3TCTreated with tenofovir disoproxil fumarate (TDF) and lamivudine (3TC) pre-exposure prophylaxis (PrEP) regimen (oral PrEP)
    HIV.C.DE21Other TDF-based regimenTreated with other tenofovir disoproxil fumarate (TDF)-based regimen (oral PrEP)
    HIV.C.DE22Dapivirine vaginal ring (DVR)Dapivirine vaginal ring (DVR) for HIV prevention
    HIV.C.DE23CAB-LALong-acting injectable cabotegravir

Source

{
  "resourceType": "ValueSet",
  "id": "HIV.C.DE17",
  "meta": {
    "profile": [
      "http://hl7.org/fhir/uv/crmi/StructureDefinition/crmi-shareablevalueset",
      "http://hl7.org/fhir/uv/crmi/StructureDefinition/crmi-publishablevalueset",
      "http://hl7.org/fhir/uv/crmi/StructureDefinition/crmi-computablevalueset"
    ]
  },
  "text": {
    "status": "extensions",
    "div": "<!-- snip (see above) -->"
  },
  "url": "http://smart.who.int/hiv/ValueSet/HIV.C.DE17",
  "version": "1.0.0",
  "name": "HIVCDE17",
  "title": "Current PrEP regimen ValueSet",
  "status": "active",
  "experimental": true,
  "date": "2025-07-08T23:21:58+02:00",
  "publisher": "WHO",
  "contact": [
    {
      "name": "WHO",
      "telecom": [
        {
          "system": "url",
          "value": "http://who.int"
        }
      ]
    }
  ],
  "description": "Value set of HIV pre-exposure prophylaxis (PrEP) regimen",
  "compose": {
    "include": [
      {
        "system": "http://smart.who.int/hiv/CodeSystem/HIVConcepts",
        "concept": [
          {
            "code": "HIV.C.DE18",
            "display": "TDF + FTC"
          },
          {
            "code": "HIV.C.DE19",
            "display": "TDF"
          },
          {
            "code": "HIV.C.DE20",
            "display": "TDF + 3TC"
          },
          {
            "code": "HIV.C.DE21",
            "display": "Other TDF-based regimen"
          },
          {
            "code": "HIV.C.DE22",
            "display": "Dapivirine vaginal ring (DVR)"
          },
          {
            "code": "HIV.C.DE23",
            "display": "CAB-LA"
          }
        ]
      }
    ]
  }
}